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Genetic deficiency of the fifth component of complement (C5) (1), a serum
glycoprotein of molecular weight 180,000 (2), is present in 39% ofinbred strains
of mice (3). Sera of deficient mice lack detectable C5 hemolytic activity and
protein (3). In addition, deficient mice produce antibody to mouse C5 when
injected with sera from C5 sufficient (normal) strains. Ooi and Colten (4)reported
that normal mouse peritoneal cells produced hemolytically active C5 in culture
and also synthesized and secreted a C5 molecule. Peritoneal macrophages from
mice deficient in C5 also synthesized, but did not secrete, a C5 molecule (5). The
isolation and characterization ofa cDNA for mouse C5 and improved techniques
for the analysis of protein synthesis by cells in culture have allowed a reexami-
nation of the molecular basis ofC5 deficiency in the mouse. We report that C5-
deficient cells contain C5 protein and C5 mRNA that differ both quantitatively
and qualitatively from the protein and mRNA in C5-sufficient cells.
Materials and Methods
Materials.
￿
Restriction enzymes were purchased from New England Biolabs (Beverly,
MA) and Bethesda Research Laboratories (Gaithersburg, MD), a-[s2P]dCTP (sp act 10
juCi/16 pmol) from New England Nuclear (Boston, MA), vanadyl ribonucleoside com-
plexes (VRC) from Bethesda Research Laboratories, and guanidinium thiocyanate from
Fluka A.G. (Buchs, Switzerland). Male mice offour differentstrains, BI0.D2/nSn (normal
or C5-sufficient), B10.D2/oSn, DBA/2, and AKR (all C5 deficient), were purchasedfrom
TheJackson Laboratory (Bar Harbor, ME). Oligo(dT) cellulose (type 7) was purchased
from Pharmacia Fine Chemicals (Uppsala, Sweden). Mouse anti-mouse C5 was prepared
as described by Cinader et al. (3); the IgG fraction ofgoat antiserum to human C3, which
crossreacted with mouse C3, was obtained from Atlantic Antibody, Scarborough, ME.
Cell Cultures, Biosynthetic Labeling, and Immunoprecipitation. 100-mg portions of
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minced lung tissue were metabolically labeled with [s5S]methionine in methionine-free
medium (6, 7). Total protein synthesis was estimated by TCA precipitation of aliquots of
lysates and extracellular media (6). Specific C3 and C5 proteins were quantitated by
immunoprecipitation, SDS-PAGE, fluorography, and digestion of specific gel slices, as
previously described (7).
Plasmids and Genomic DNA Preparation. Plasmid pC5Mo has been isolated from a
BIO.WR mouse (C5 sufficient with DNA library and characterized by Wetsel et al. (8). A
4.2-kb insert corresponding to the murine C5 cDNA was obtained by digestion of pMoC5
with Xho 1, followed by isolation on low-melting-temperature agarose. Preparation of
murine liver DNA was carried out as described previously (9).
RNA Preparation. Total cellular RNA was prepared from frozen organ powder by
lysis in guanidinium thiocyanate and cesium chloride gradient ultracentrifugation (9).
Cytoplasmic RNA was extracted from dounce homogenized livers by phenol/chloro-
form/isoamyl alcohol extraction and ethanol precipitation (9). Nuclear RNA was prepared
from livers as described by Maniatis et al. (9), except that the homogenized tissue was
lysed in the presence of 32 mM sucrose in 1 mM KCI, I MM MgC12, 100 mM NaOAc,
pH 6.0, 0.25% Triton X-100 and 10 mM VRC; the resulting nuclear pellet was washed
twice in the same solution without Triton X-100. Poly(A)+ RNA was purified from equal
amounts of RNA (usually 100 kg) using oligo(dT)-cellulose (8) and was subjected to
Northern analysis using mouse C5 cDNA, mouse C3 cDNA (the generous gift of Dr.
Morinobu Takahashi, Kanazawa University, Kanazawa, Japan), and mouse factor B cDNA
(the generous gift of Dr. Harvey R. Colten, Washington University, St. Louis, MO)
radiolabeled with s2P by nick translation.
Results
Tissue Localization of C5 mRNA.
￿
Total cellular RNA was obtained from the
liver, lung, heart, spleen, intestine, and kidney of a B10 .D2/nSn (C5-sufficient
mouse). Poly(A)+ mRNA was extracted from 100 jug total cellular RNA with
oligo(dT) to increase the sensitivity of detection of specific mRNA signals.
Northern analysis indicated that the liver and lung were the only organs that
contained C5 mRNA (Fig. 1). In contrast, all six organs contained C3 mRNA
and all organs except the heart contained factor B mRNA. A doublet of the
factor B mRNA was observed in the intestine and kidney.
Synthesis of C5 Protein in Lung Tissue from C5-sufficient and C5-deficient
Mice. For the C5-sufficient lung tissue, a single-chain C5 molecule (^-177 kD)
(pro-C5) was present in the intracellular lysate within as early as 15 min of a
continuous pulse with [35S]methionine (data not shown). By 30 min, the amount
of the pro-C5 had increased and a (^-120 kD) and a (^-78 kD) chains were also
present in the cell lysate. After 24, h the a and # chains were prominent in the
extracellular medium; there was also a small amount of pro-C5 in the medium .
The C5-deficient tissue had a protein (^-187 kD) in the cell lysate at 60 min, but
no protein was visible in the extracellular medium, even at 24 h. The amount of
pro-C5 protein in the C5-deficient tissue after the 60-min pulse was only 5% of
the amount in the C5-sufficient tissue, as determined by soft-laser densitometry
of autoradiographs. In contrast, the amounts of C3 protein synthesized and
secreted by the C5-sufficient and C5-deficient lung tissue were similar (data not
shown).
Characterization of C5 mRNA from C5-sufficient and C5-deficient Mice.
￿
C5-
sufficient cells contained a single species of C5 mRNA, with a size of ^-6.0 kb;
this result was observed for both total cellular RNA (data not shown) and
cytoplasmic RNA (Fig. 2). C5-deficient cells contained this 6.0-kb species, but1444
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FIGURE 1 . Tissue localization of C5 mRNA .
Poly(A)* RNA was extracted using oligo(dT)-cel-
lulose from equalamounts (100 wg) oftotal cellular
RNA obtained from organs of a C5-sufficient
mouse (B.IOD2/nSn) . TheRNA was subjected to
Northern analysis using mouse C5 cDNA, mouse
C3cDNA,and mouse factor B cDNA radiolabeled
with 'YP via nick translation . The upper photo
shows the Northern blot after being exposed to x-
ray film for 16 h . Thelower photo shows thesame
Northern blot aftera 5-d exposure to x-ray film to
demonstrate the presence of C5 mRNA only in
the liver andthe lung. (Li) liver, (L) lung, (H) heart,
(K) kidney, (1) intestine, (S) spleen .
also contained a second and higher molecular mass form of C5 mRNA (^-6.5
kb) . This result was observed for both total cellular and cytoplasmic RNA in all
three deficient strains; cytoplasmic RNA from one deficient strain, BIO.D2/oSn,
is shown in Fig . 2 . In addition to the qualitative differences, between the normal
and deficient RNAs, the C5 mRNA from the deficient mice was decreased in
quantity when compared with the amounts in the normal mice . In five separate
experiments, amounts of C5mRNA in the deficient RNA were only 5% of the
amounts in the normal RNA, as determined by soft-laser densitometry of the
radioautographs . Factor B mRNA content of the same blots was similar (data
not shown), indicating that the reduction ofC5mRNA content in the C5 deficient
strains was not due to variations in amounts of total poly(A)' RNA analyzed per
lane . The nuclear fractions from both normal and deficient animals contained
only a single species of RNA that was the same size as the larger molecular mass
form present in the cytoplasm of the deficient animal (Fig . 2) . The amount of
poly(A)+ C5 RNA in the nucleus of the C5-deficient mouse was reduced in
quantity compared with that in normal mice .
Southern Analysis ofNormal and C5-deficient DNA .
￿
For digestion with Hind
III and Pvu II, the patterns for the C5 DNA from the three C5-deficient strains
were identical and distinct from the C5-sufficient pattern (Fig. 3) . For Hind 111,
the deficient DNA contained an additional band with a size of -6.0 kb andWHEAT ET AL .
￿
BRIEF DEFINITIVE REPORT
￿
1445
FIGURE 2.
￿
Analysis of C5 mRNA in cytoplasmic
and nuclear compartments in C5-sufficient andC5-
deficient mice . Poly(A)* RNA was extracted using
oligo(dT)-cellulose from equal amounts of cyto-
plasmic and nuclear RNA (100 wg) from C5-suffi-
cient (N) and C5-deficient (O) mice and subjected
to Northern analysis using a "P nick-translated
mouse C5 cDNA . The band labeledHMW is the
6.5-kbmRNA species found in the nucleus ofboth
animals yet found also in the cytoplasm of the C5-
deficient mouse . The lower band, labeled LMW,
is the mRNA species found alone in the cytoplasm
of the C5-sufficient mouse and present with the
HMWin the cytoplasm of the C5-deficient mouse .
FIGURE 3.
￿
Southern analysis of C5-sufficient and C5-deficient DNA. Liver DNA from the
C5-sufficient andthree C5-deficient strainswere digested using restriction endonucleases Hind
III and Pvu II and subjected to Southern analysis usinga s2P nick-translated mouse C5 cDNA .
Genomic DNA was isolated from a C5-sufficient (BIO.D2/nSn) mouse (A) and three C5-
deficient mice; BIO.D2/oSn (B), AKR/J (C), and DBA/2 (D) . For both Pvu II and Hind III,
all three C5-deficient mice demonstrated the same restriction pattern that was different when
compared with the C5-sufficient mouse .
lacked a band of ^-3.0 kb . For Pvu II, the deficientDNA contained an additional
band with a size of ^-4.3 kb . For digestions with Pst I and Msp I, the patterns for
DNA from the the C5-deficient strains were not different from the patterns for
the C5-sufficient DNA (data not shown) . When the same Southern blots were1446
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probed with "I'-factor B cDNA, no differences were observed between the C5-
deficient and C5-sufficient DNA (data not shown).
Discussion
We report that mice deficient in serum C5 (C5-deficient or C5D) differ from
normal mice (C5-sufficient or C5S) both quantitatively and qualitatively in the
C5 protein synthesized within the cell, the C5 mRNA present in the cytoplasm
and nucleus, and the structure ofthe C5 gene. The presence in the C5-deficient
cells of a single-chain C5 precursor that is not processed further is consistent
with the previous findings of Ooi and Colten (5). The comparable decreases in
C5 protein and C5 mRNA in the C5-deficient cells compared with C5-sufficient
cells suggest that C5-deficient mRNA is translated with normal efficiency, but
that it codes for an abnormal protein.
In addition to not being processed into a two-chain molecule, the protein
synthesized by the C5-deficient cells also had a larger molecular mass then the
precursor protein in the normal cells. Further studies will be required to
determine if the increased mass of the deficient molecule is due to increased
numbers of amino acids or an increase in the degree of glycosylation of the
molecule or both. The defect(s) in the C5D pro-C5 molecule that prevent(s) its
processing and eventual secretion and the relationship of the defect(s) to the
abnormalities in RNA and DNA have not been addressed in this study. Possible
abnormalities include inappropriate levels ofglycosylation (10) or an abnormality
in the NH2-terminal sequence of the protein necessary for protein translocation
across and integration into the endoplasmic reticulum membrane (11).
One of the most striking findings in the C5-deficient cells is the presence of
the two forms of cytoplasmic C5 mRNA. The larger form of mRNA present in
the cytoplasm could beexplained byan abnormality(ies) in the primary transcript
that retards the processing of the C5 RNA (e.g., due to inefficient splicing). The
decreased C5 mRNA content in the C5-deficient nuclear and cytoplasmic RNA
would be the result of turnover of this defective and inefficiently processed C5
RNA in the nucleus. The concept of unspliced RNA being transported to the
cytoplasm is consistent with the findings of Green et al. (12). The decreased
levels of nuclear and cytoplasmic mRNA in the C5-deficient cells also could be
due to a defect in either polyadenylation or capping of the C5 RNA precursor
and subsequent instability in the transcript. However these seem unlikely as
primary explanations because the nuclear form of the C5 mRNA in the C5-
deficient cells is polyadenylated and the C5-deficient mRNA has approximately
the expected translation efficiency . The C5 deficiency provides another model
with which to study the relationship between RNA structure and splicing effi-
ciency and accuracy.
Summary
C5-deficient mice differed from C5-sufficient mice both quantitatively and
qualitatively in C5 protein, C5 mRNA, and the C5 gene. C5-deficient protein
was presentas decreased amounts ofan unprocessed, single-chain precursor. C5-
deficient mRNA was decreased in amount and present in two forms, the smallerWHEAT ET AL.
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of which was the same as the single form in normal cells. Nuclei from both
normal and deficient cells contained the larger form of C5 mRNA, and C5-
deficient DNA demonstrated differences from the normal pattern on Southern
analysis for two restriction enzymes. These data suggest that the primary tran-
script of the C5-deficient gene is abnormal, retarding the processing of the C5
mRNA, and that the C5-deficient mRNA codes for an abnormal protein.
We thank Denise Eidlen for excellent technical assistance andJane Watkins for preparation
of the manuscript.
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